BridgeBio logo

BridgeBio Employee Directory

Biotechnology ResearchCalifornia, United States1001-5000 Employees

BridgeBio is a biotechnology research company headquartered in Palo Alto, California, United States, with 501-1000 employees. It focuses on developing therapies for genetic conditions, aiming to translate advances in genetic science into real-world patient impact. The company is active in drug development within the biotechnology research sector. In 2026, BridgeBio submitted an NDA to the FDA for encaleret to treat ADH1, and the FDA accepted an NDA for BBP-418 for LGMD2I/R9 with priority review. Public disclosures indicate ongoing regulatory activity and investor coverage related to its programs.

Find BridgeBio employees' phone numbers or email addresses

BridgeBio Global Highlights

Location
Employees

North America
920

Minus sign iconPlus sign icon
  • United States Of America
    919
  • Canada
    1

Europe
44

Minus sign iconPlus sign icon
  • Switzerland
    24
  • Netherlands
    8
  • France
    4
  • United Kingdom Of Great Britain And Northern Ireland
    3
  • Germany
    2
  • Croatia
    1
  • Slovenia
    1
  • Sweden
    1

Asia
11

Minus sign iconPlus sign icon
  • China
    7
  • India
    2
  • Pakistan
    1
  • Indonesia
    1

Africa
1

Minus sign iconPlus sign icon
  • Ghana
    1

Oceania
1

Minus sign iconPlus sign icon
  • Australia
    1

South America
1

Minus sign iconPlus sign icon
  • Argentina
    1

BridgeBio's Leadership

  • Ceo And Founder at BridgeBio
    N. K.
    Ceo And Founder
  • Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio at BridgeBio
    M. O.
    Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio
  • Ceo, Skeletal Dysplasias (qed Therapeutics) at BridgeBio
    J. T.
    Ceo, Skeletal Dysplasias (qed Therapeutics)
  • Cso And Site Head, Gene Therapy at BridgeBio
    C. B.
    Cso And Site Head, Gene Therapy
  • Chief Regulatory Officer at BridgeBio
    A. N.
    Chief Regulatory Officer
  • Chief Operating Officer, Cardiovascular at BridgeBio
    J. L.
    Chief Operating Officer, Cardiovascular
  • Chief Development Officer, Cardiovascular at BridgeBio
    L. K.
    Chief Development Officer, Cardiovascular
  • Chief Accounting Officer at BridgeBio
    A. R.
    Chief Accounting Officer

BridgeBio Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Operations
  • Engineering
  • Finance
  • Program & Project Management
  • Other
  • Sales
  • Biotechnology
  • Legal
  • Administrative
  • Business
  • Quality Assurance
  • Pharmaceuticals

Contact profiles from BridgeBio

Name
Title
Contact
Location
Last Update
  • Ceo And Founder at BridgeBio
    N. K.
    Ceo And Founder
    Bay
    May 03, 2026
  • Chief Regulatory Officer at BridgeBio
    A. N.
    Chief Regulatory Officer
    Aug 28, 2026
  • Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio at BridgeBio
    M. O.
    Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio
    Bay
    Aug 07, 2026
  • Chief Operating Officer, Cardiovascular at BridgeBio
    J. L.
    Chief Operating Officer, Cardiovascular
    Bay
    Sep 03, 2026
  • Ceo, Skeletal Dysplasias (qed Therapeutics) at BridgeBio
    J. T.
    Ceo, Skeletal Dysplasias (qed Therapeutics)
    Bay
    Aug 26, 2026
  • Cso And Site Head, Gene Therapy at BridgeBio
    C. B.
    Cso And Site Head, Gene Therapy
    Jul 15, 2026
  • Chief Development Officer, Cardiovascular at BridgeBio
    L. K.
    Chief Development Officer, Cardiovascular
    Bay
    Sep 01, 2026
  • Senior Manager, Small Molecule Drug Substance, Cmo at BridgeBio
    O. W.
    Senior Manager, Small Molecule Drug Substance, Cmo
    Croatia
    Jun 25, 2026
  • Chief Accounting Officer at BridgeBio
    A. R.
    Chief Accounting Officer
    Oct 21, 2024
  • President at BridgeBio
    A. B.
    President
    Oct 23, 2024

Frequently Asked Questions

What is BridgeBio known for?

Minus sign iconPlus sign icon
BridgeBio was founded in 2014 and operates in the Biotechnology Research industry. Explore BridgeBio's company overview page for more information.

What is BridgeBio's most common email format?

Minus sign iconPlus sign icon
BridgeBio employees' email format typically follows the pattern of First.Last@bridgebio.com. Trying to find reliable and up-to-date employee contact data? Find more BridgeBio email formats with LeadIQ.

How many employees does BridgeBio have currently?

Minus sign iconPlus sign icon
BridgeBio has approximately 1K employees as of August 2026. These team members are located across 6 continents, including North America, Europe and Asia.

Who are BridgeBio's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, BridgeBio's key employees include:

  • Ceo And Founder: N. K.
  • Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio: M. O.
  • Ceo, Skeletal Dysplasias (qed Therapeutics): J. T.
  • Cso And Site Head, Gene Therapy: C. B.
  • Chief Regulatory Officer: A. N.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.